Novartis UK

Home
Novartis UK

Welcome to our page.

Please take a look at our Community Guidelines for details about how to use and interact with our page: https://tinyurl.com/y7k8dlo3

01/08/2025

“31 is a significant number. It's the number of women who die from metastatic breast cancer every day in the UK, that's 1 woman every 45 minutes. Knowledge is power and I will continue to use my voice to demand better awareness of signs and symptoms of the disease, for women like myself living with metastatic breast cancer. We don't take no for an answer. And if you're someone currently living with MBC, understand your body to deal with issues that come along. These can sometimes be out of the blue, so be kind to yourself".

Jo is an ambassador for which is developed and funded by Novartis Pharmaceuticals UK Limited. She was diagnosed at 38 with primary breast cancer and lived cancer free for 7 years before receiving news that her cancer had recurred. Since her diagnosis, she founded ABC diagnosis & METUPUK to increase awareness on the realities of living with metastatic breast cancer and the importance of understanding recurrence. Jo continues to advocate for increased research and access to clinical trials, as well as better support for patients and their families.

There are many ways to tell a story and this year we've invited Kristina Varaksina Photography to share her intimate take on the experiences of the Moments That Count ambassadors. Through ‘Photo Essays’, Kristina shares the highs and lows, and all the moments that count when living with breast cancer.

Learn more about secondary breast cancer here on the Moments That Count campaign website - www.momentsthatcount.co.uk. Moments That Count campaign is developed and funded by Novartis Pharmaceuticals UK Limited.

UK | July 2025 | FA-11419828-1

18/07/2025

For many living with early breast cancer, ringing the ‘end of treatment’ bell feels like the finish line.

But the journey to remission is rarely a straight path.

Amy Dowden and Leanne Pero express the emotional highs and lows of life after breast cancer treatment.

How the fear of recurrence once held them back.
How they found the strength to take back control.
How they keep moving forward.

Watch their inspiring story and discover how they’ve transformed fear into resilience.

Visit www.keep-ahead.co.uk to watch the full film and learn more about the campaign.

The ‘Beyond the Bell’ film is a part of the Keep Ahead disease awareness campaign which has been created and funded by Novartis Pharmaceuticals UK. This content is intended for the general public and people living with early breast cancer.

UK | April 2025 | FA-11374119

14/05/2025

“I’ve slowly year by year started to find glimmers of myself before cancer. It’s definitely made me less tolerant of certain things as life is way too short to sweat the small stuff. I might have secondary breast cancer, but I am also a mum, a wife, a businesswoman and cancer can’t take that away."

Lisa is an ambassador for . She was diagnosed with secondary breast cancer in 2017 following a primary breast cancer diagnosis in that same year. Lisa has since dedicated her time to charity, supporting the metastatic breast cancer community and advocating passionately on the importance of prioritising physical and mental health in breast cancer. Lisa tells a story of rebuilding her life after diagnosis, finding joy and herself again in her passion – theatre.

There are many ways to tell a story and this year we've invited photographer Kristina Varaksina Photography to share her intimate take on the experiences of the Moments That Count ambassadors. Through ‘Photo Essays’, Kristina shares the highs and lows, and all the moments that count when living with breast cancer.

Learn more about secondary breast cancer here on the Moments That Count campaign website – www.momentsthatcount.co.uk.

Moments That Count campaign is developed and funded by Novartis Pharmaceuticals UK Limited.

UK | March 2025 | FA-11311140-1

06/05/2025

“My Granny Jean is a very special woman. As she has gotten older, she is much less able to do things but I still try to spend time with her. Nine years ago, my granny lost her husband Jack, and then only a year later her daughter Helen. My mum. Despite this she shows strength and resilience.”

Laura is an ambassador for . She was diagnosed with early breast cancer at 25 and with secondary breast cancer at 28. She continuously campaigns to raise awareness about secondary breast cancer and champions those living with it.

There are many ways to tell a story and this year we've invited photographer Kristina Varaksina Photography to share her intimate take on the experiences of the Moments That Count ambassadors. Through ‘Photo Essays’, Kristina shares the highs and lows, and all the moments that count when living with breast cancer.

Learn more about secondary breast cancer here on the Moments That Count campaign website – www.momentsthatcount.co.uk.

Moments That Count campaign is developed and funded by Novartis Pharmaceuticals UK Limited.

UK | January 2025 | FA-11311138

25/04/2025

“I see myself now as feisty, assertive and strong. I know myself much better and am not afraid to say how I feel and ask for what I want. When I was diagnosed, I took the decision to go flat - I had 34GG breasts, eighteen months later I had none. I used to wear huge bras, which constricted my everyday life, especially during exercise. I no longer wear bras which is so freeing and liberating.”

Juliet is an ambassador for . She was diagnosed with breast cancer in 2016 and has since made the decision to undergo two mastectomies. She is now in complete remission, living flat and strongly advocates for informed choices, and for better conversations between primary and secondary breast cancer patients.

There are many ways to tell a story and this year we've invited photographer Kristina Varaksina Photography to share her intimate take on the experiences of the Moments That Count ambassadors. Through ‘Photo Essays’, Kristina shares the highs and lows, and all the moments that count when living with breast cancer.

Learn more about secondary breast cancer here on the Moments That Count campaign website - www.momentsthatcount.co.uk.

Moments That Count campaign is developed and funded by Novartis Pharmaceuticals UK Limited.

UK | January 2025 | FA-11311132

14/04/2025

"I always find treatment days very emotionally tiring, and this day was no different. I will calm myself to get in the zone before, during, and even after my treatment - shutting out my family life and all the demands on my time, so I can focus on the process. On the drive to the hospital, I listen to a podcast or music to get me in the right headspace. I reflect on how the last 3 weeks of the cycle have been and if there is anything I need to tell my nurses and care team, all of whom have been like family to me. We always hug when we first see each other in the unit and when I say goodbye until the next time – exactly like I would with my daughter or my sister."

Claire was diagnosed with breast cancer in 2016 and lives with secondary breast cancer. She is actively involved in a wide range of initiatives to support the secondary breast cancer community, as well as being one of the ambassadors of campaign. Awareness and support for this patient group is crucial, given it has historically been neglected. There are many ways to tell a story and this year we've invited photographer Kristina Varaksina to share her intimate take on the experiences of the Moments That Count ambassadors. Through ‘Photo Essays’, Kristina shares the highs and lows, and all the moments that count when living with breast cancer.

Learn more about secondary breast cancer here on the Moments That Count campaign website - www.momentsthatcount.co.uk.

Moments That Count campaign is developed and funded by Novartis Pharmaceuticals UK Limited.

UK | January 2025 | FA-11311124

09/04/2025

Since 2021, campaign has been raising awareness of secondary breast cancer — giving the platform to those living with cancer to better support conversations and highlight what’s important when it comes to living with the diagnosis. This year we’ve invited photographer Kristina Varaksina Photography to tell the stories of Lisa, Jo, Laura, Claire and Juliet through her camera lens, exploring themes of and .

There are many ways to tell a story, and we hope ‘Photo Essays’ created by Kristina and our ambassadors will help share the highs and lows, and all the moments that count when living with breast cancer.

Learn more about secondary breast cancer here on the Moments That Count campaign website - www.momentsthatcount.co.uk.

Moments That Count campaign is developed and funded by Novartis Pharmaceuticals UK Limited.

UK | January 2025 | FA-11328561

18/10/2024

WEST Youth Zone is a new state-of-the-art facility offering West London’s young people a safe and inspiring place for their leisure time.

Since its opening, WEST has already positively impacted the lives of over 2,000 young people.

As founding members, we’re committed to help build a better and more equitable future for our young people, shaping the next generation of leaders and innovators.

Curious to know more? Watch the full conversation here: https://youtu.be/sOIpMfHijuQ?si=a69RAaQF2zf42daM

30/08/2024

Chronic myeloid leukaemia (CML) is a rare type of blood cancer that causes the bone marrow to produce too many immature and underdeveloped white blood cells, known as myeloid cells. Around 830 people are diagnosed with chronic myeloid leukaemia (CML) each year in the UK.

Being diagnosed with chronic myeloid leukaemia (CML) does not mean you lose control of your future. Working closely with your cancer care team to create and refine your personal treatment plan is a great way to help you gain control, stay on track, and live your life the way you want.

If you have been diagnosed with CML, or know somebody that has, visit our website for information and resources: https://bit.ly/help-get-your-cml-back-on-track.

Get on track. Keep track. Change track.

UK | July 2024 | 433066

This campaign is developed and funded by Novartis Pharmaceuticals UK.

29/07/2024

Around 830 people are diagnosed with chronic myeloid leukaemia (CML) each year in the UK.

Mark was diagnosed with CML in 2011. Mark’s journey hasn’t been easy, but he is now in a place where he can spend time with his supportive wife, Elaine, at home.

If you have been diagnosed with CML, or know somebody who has, visit our website to learn more about Mark’s journey and access our free CML resources: https://bit.ly/help-get-your-cml-back-on-track

Get on track. Keep track. Change track.

UK | July 2024 | 433066

This campaign is developed and funded by Novartis Pharmaceuticals UK.

09/07/2024

In the UK, a baby is born with Spinal Muscular Atrophy (SMA) every five days.

SMA is a rare genetic disease that has a devastating impact on babies and their families. Detecting it early can make a world of difference, but without testing at birth, it's too late to prevent irreversible damage.

Over 65% of EU countries have already added SMA testing to their newborn screening. Now, it’s time for the UK to do the same!

Join us in raising awareness and demanding change. Because for babies born with SMA

05/07/2024

Chronic myeloid leukaemia (CML) is a rare type of blood cancer that causes the bone marrow to produce too many immature and underdeveloped white blood cells, known as myeloid cells. It develops slowly and typically affects people over the age of 60.

Mark was diagnosed with CML in 2011 after experiencing sweats, tiredness, stomach and spleen pain for three weeks. Mark’s advice is, “If something isn’t working for you, make an appointment with your doctor or nurse.”

If you have been diagnosed with CML, or know somebody who has, visit our website for information and resources: https://bit.ly/help-get-your-cml-back-on-track.

Understanding and taking an active role in managing your CML symptoms could be the first step towards getting on track and living life the way you want.

Get on track. Keep track. Change track.

UK | July 2024 | 433066

This campaign is developed and funded by Novartis Pharmaceuticals UK.

Address

Opening Hours

Monday	09:00 - 17:00
Tuesday	09:00 - 17:00
Wednesday	09:00 - 17:00
Thursday	09:00 - 17:00
Friday	09:00 - 17:00

Telephone

+441276692255

Website

https://www.novartis.com/uk-en/

Alerts

Be the first to know and let us send you an email when Novartis UK posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Novartis UK:

Want your practice to be the top-listed Clinic?

Country:

City:

Our Story

Novartis UK is a healthcare company whose mission is to discover new ways to improve and extend people’s lives.

We harness the power of science to push boundaries, develop breakthrough treatments and deliver them directly to the millions of people in the UK that need them.

We are proud to be a leader within the life sciences industry in the UK. Our work in the UK spans three locations: White City Place, Watchmoor Park and Grimsby. We employ around 1,300 people in the UK who are united by a shared purpose of putting patients at the heart of everything we do.

Discovering new treatments requires imagination and visionary thinking, combined with determination and rigour. Our R&D activities are enhanced by working with world renowned UK healthcare professionals and NHS trusts.